Moreover, we induced the knockdown and overexpression of ASF1b to explore its function and mechanism, which revealed that the disrupting the ASF1b not only suppressed cancer cell proliferation in vitro but also slowed the growth of GC cell-derived xenograft tumors in vivo. This evidence concerns the gene ASF1B and gastric cancer.